BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38153640)

  • 1. Postoperative Complications After Neoadjuvant Chemotherapy Versus Upfront Surgery in Gastric Adenocarcinoma: A Population-Based Nationwide Study in Finland.
    Putila E; Helminen O; Helmiö M; Huhta H; Jalkanen A; Kallio R; Koivukangas V; Kokkola A; Laine S; Lietzen E; Louhimo J; Meriläinen S; Pohjanen VM; Rantanen T; Junttila A; Ristimäki A; Räsänen JV; Saarnio J; Sihvo E; Toikkanen V; Tyrväinen T; Valtola A; Kauppila JH;
    Ann Surg Oncol; 2024 Apr; 31(4):2689-2698. PubMed ID: 38153640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based nationwide incidence of complications after gastrectomy for gastric adenocarcinoma in Finland.
    Putila E; Helminen O; Helmiö M; Huhta H; Jalkanen A; Kallio R; Koivukangas V; Kokkola A; Laine S; Lietzen E; Louhimo J; Meriläinen S; Pohjanen VM; Rantanen T; Ristimäki A; Räsänen JV; Saarnio J; Sihvo E; Toikkanen V; Tyrväinen T; Valtola A; Kauppila JH
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Neoadjuvant Chemotherapy Does not Increase Postoperative Complications Compared with Upfront Surgery in Gastric Adenocarcinoma: A Population-Based, Nationwide Study in Finland.
    Emilia P; Helminen O; Kauppila JH;
    Ann Surg Oncol; 2024 Apr; 31(4):2711-2712. PubMed ID: 38206506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy].
    Cui H; Zhang KC; Cao B; Deng H; Liu GX; Cui JX; Xie TY; Liang WQ; Zhang QP; Wang N; Chen L; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):153-159. PubMed ID: 33508921
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
    Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
    Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
    J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neoadjuvant versus upfront surgery for treatment of locally advanced gastric cancer.
    Omarov N; Uymaz DS; Gurbuz B; Selcukbiricik F; Cigtaskin O; Yesilsoy M; Ozoran E; Balik E; Bugra D
    Ann Ital Chir; 2023; 94():569-579. PubMed ID: 37724662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer.
    Téoule P; Trojan J; Bechstein W; Woeste G
    Dig Surg; 2015; 32(4):229-37. PubMed ID: 25966823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer.
    Marcus SG; Cohen D; Lin K; Wong K; Thompson S; Rothberger A; Potmesil M; Hiotis S; Newman E
    J Gastrointest Surg; 2003 Dec; 7(8):1015-22; discussion 1023. PubMed ID: 14675711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
    Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien-Dindo system.
    Lee KG; Lee HJ; Yang JY; Oh SY; Bard S; Suh YS; Kong SH; Yang HK
    J Gastrointest Surg; 2014 Jul; 18(7):1269-77. PubMed ID: 24820136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the clinically most relevant postoperative complications after gastrectomy: a population-based cohort study.
    Gertsen EC; Goense L; Brenkman HJF; van Hillegersberg R; Ruurda JP;
    Gastric Cancer; 2020 Mar; 23(2):339-348. PubMed ID: 31482476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neoadjuvant treatment combined with radical gastrectomy on postoperative complications and prognosis of gastric cancer patients.
    Zhou Y; Tian Z; Zeng J; Zhou W; Wu K; Shen W
    Scand J Gastroenterol; 2021 Nov; 56(11):1343-1348. PubMed ID: 34415219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy.
    Shrikhande SV; Barreto SG; Talole SD; Vinchurkar K; Annaiah S; Suradkar K; Mehta S; Goel M
    World J Surg Oncol; 2013 Feb; 11():31. PubMed ID: 23375104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Postoperative Complications After Gastrectomy for Gastric Cancer with Antecolic Versus Retrocolic Reconstruction: A Population-Based Study.
    Junttila A; Helminen O; Helmiö M; Huhta H; Jalkanen A; Kallio R; Koivukangas V; Kokkola A; Laine S; Lietzen E; Louhimo J; Meriläinen S; Pohjanen VM; Rantanen T; Ristimäki A; Räsänen JV; Saarnio J; Sihvo E; Toikkanen V; Tyrväinen T; Valtola A; Kauppila JH;
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38750189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study.
    Holmberg D; Kauppila JH; Asplund J; Leijonmarck W; Mattsson F; Lagergren J
    Gastric Cancer; 2024 May; 27(3):590-597. PubMed ID: 38430275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of neoadjuvant chemotherapy on resectability of locally-advanced gastric adenocarcinoma: a clinical trial.
    Hashemzadeh S; Pourzand A; Somi MH; Zarrintan S; Javad-Rashid R; Esfahani A
    Int J Surg; 2014 Oct; 12(10):1061-9. PubMed ID: 25157992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.